A comparison study of inhomogeneous magnetization transfer (ihMT) and magnetization transfer (MT) in multiple

Lei Zhang1, Baohong Wen2, Tao Chen1

  • 1Department of Radiology, Baoji Center Hospital, Baoji, Shaanxi, People's Republic of China.

Abstract

Insights

Inhomogeneous magnetization transfer (ihMT) shows strong correlation with disability in multiple sclerosis (MS) patients. This new biomarker may improve demyelination assessment in MS, outperforming traditional methods.

Area of Science:

  • Neuroimaging
  • Biomarker Discovery
  • Central Nervous System Disorders

Background:

  • Multiple sclerosis (MS) is a central nervous system disorder impacting function.
  • Current clinical scales for MS severity lack lesion-specific information.
  • Magnetic resonance imaging (MRI) in MS faces challenges with myelin specificity.

Purpose of the Study:

  • Investigate inhomogeneous magnetization transfer (ihMT) as a novel biomarker for demyelination in MS.
  • Evaluate the efficacy of ihMT in assessing MS severity compared to conventional magnetization transfer (MT) imaging.

Main Methods:

  • Eighteen relapsing-remitting MS patients and sixteen healthy volunteers underwent MRI including MT and ihMT imaging.
  • Expanded Disability Status Scale (EDSS) assessments were performed on all participants.
  • Statistical analyses included t-tests for group comparisons and Spearman correlation for biomarker-EDSS relationships.

Main Results:

  • ihMT parameters (ihMTR and qihMT) showed significant differences between healthy white matter (HWM) and normal-appearing white matter (NAWM).
  • All MT and ihMT parameters demonstrated significant differences between HWM and MS lesions.
  • Strong negative correlations were observed between ihMT parameters and EDSS scores (r = -0.704 to -0.739).

Conclusions:

  • Inhomogeneous magnetization transfer (ihMT) imaging exhibits a stronger correlation with the EDSS score than conventional MT imaging in MS.
  • ihMT shows potential as a valuable biomarker for assessing demyelination in multiple sclerosis.
  • Whole-brain analysis at 3.0T supports ihMT's utility in MS evaluation.